NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant - Insider Trading and Ownership Report - SEC Form 3, 4, 5

NewAmsterdam Pharma Company N.V. - Equity Warrant

Total Insiders17
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

NewAmsterdam Pharma Company N.V. - Equity Warrant insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Juliette Berangere Audet Chief Business Officer - [O] 15.104 15.104
Bain Capital Life Sciences Investors, LLC 10% Owner - [10%] 10.473.913 10.473.913
Davidson Michael H. Chief Executive Officer, Director - [D] [O] 174.144 174.144
ForGrowth NAP B.V. 10% Owner - [10%] 10.656.172 10.656.172
Gulfo Adele M. Director - [D] 14.260 14.260
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
William A Jr Jones Chief Commercial Officer - [O] 43.000 43.000
Johannes Jacob Pieter Kastelein Chief Scientific Officer, Director - [D] [O] 69.302 69.302
Douglas F Kling Chief Operating Officer - [O] 44.000 44.000
Louise Frederika Kooij Chief Accounting Officer - [O] 24.353 24.353
Louis G Lange Director - [D] 10.360 10.360
William Lewis Director - [D] 10.360 10.360
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Michael F III Marino See Remarks - [O] 55.000 55.000
McKenna Mark C. Director - [D] 10.360 10.360
John W Smither Director - [D] 10.360 10.360
Mayur Ian Somaiya Chief Financial Officer - [O] 58.382 58.382
James N Topper Director - [D] 6.829.524 6.829.524
der Kamp Hilde Johanna van Director - [D] 10.360 10.360

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-09-15 Topper James N 660 23,6953 660 23,6953 15.639 72 41.4500 11.719 74,94
2025-09-08 Topper James N 1.260 24,9900 1.260 24,9900 31.487
2025-08-11 Topper James N 471 23,9787 471 23,9787 11.294
2025-06-25 Topper James N 1.260 18,2632 1.260 18,2632 23.012
2025-06-24 Topper James N 2.520 18,4343 2.520 18,4343 46.454
2025-06-16 Topper James N 8.584 19,4992 8.584 19,4992 167.381
2025-03-26 Topper James N 1.135 22,4851 1.135 22,4851 25.521
2025-03-04 Topper James N 4.005 21,0245 4.005 21,0245 84.203
2024-09-26 Audet Juliette Berangere 1.104 15,7000 1.104 15,7000 17.333

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-03-11 LANGE LOUIS G 44.173 30,4100 44.173 30,4100 1.343.301 2 28.6200 -79.069 -5,89
2026-03-11 LANGE LOUIS G 446 31,2300 446 31,2300 13.929
2026-03-09 Kastelein Johannes Jacob Pieter 101.409 30,2900 101.409 30,2900 3.071.679
2026-03-06 Kastelein Johannes Jacob Pieter 94.124 30,3200 94.124 30,3200 2.853.840
2026-03-06 LANGE LOUIS G 28.186 29,4100 28.186 29,4100 828.950
2026-03-05 Kastelein Johannes Jacob Pieter 104.467 30,3000 104.467 30,3000 3.165.350
2026-03-02 Davidson Michael H. 443.707 33,2500 443.707 33,2500 14.753.258
2026-02-26 Davidson Michael H. 17.924 34,4400 17.924 34,4400 617.303
2026-02-26 Davidson Michael H. 165.408 33,6300 165.408 33,6300 5.562.671

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-12 2026-03-11 4 LANGE LOUIS G NAMS Ordinary Shares S - Sale D 31,2300 -446 -14 10.360
2026-03-12 2026-03-11 4 LANGE LOUIS G NAMS Ordinary Shares S - Sale D 30,4100 -44.173 -1.343 10.806
2026-03-10 2026-03-09 4 LANGE LOUIS G NAMS Ordinary Shares X - Other D 11,5000 44.619 513 54.979
2026-03-10 2026-03-06 4 LANGE LOUIS G NAMS Ordinary Shares S - Sale I 29,4100 -28.186 -829 0
2026-03-09 2026-03-09 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 30,2900 -101.409 -3.072 69.302
2026-03-09 2026-03-09 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise I 101.409 170.711
2026-03-09 2026-03-06 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 30,3200 -94.124 -2.854 69.302
2026-03-09 2026-03-06 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise I 94.124 163.426
2026-03-09 2026-03-05 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 30,3000 -104.467 -3.165 69.302
2026-03-09 2026-03-05 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise I 104.467 173.769
2026-03-02 2026-03-02 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 33,2500 -443.707 -14.753 174.144
2026-03-02 2026-03-02 4 Davidson Michael H. NAMS Ordinary Shares M - Exercise D 443.707 617.851
2026-02-26 2026-02-26 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 34,4400 -17.924 -617 174.144
2026-02-26 2026-02-26 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 33,6300 -165.408 -5.563 477.783
2026-02-26 2026-02-26 4 Davidson Michael H. NAMS Ordinary Shares M - Exercise D 183.332 643.191
2026-02-26 2026-02-25 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 36,6800 -1.300 -48 459.859
2026-02-26 2026-02-25 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 35,9600 -10.436 -375 461.159
2026-02-26 2026-02-25 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 35,1100 -46.517 -1.633 471.595
2026-02-26 2026-02-25 4 Davidson Michael H. NAMS Ordinary Shares M - Exercise D 58.253 518.112
2026-02-26 2026-02-24 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 36,4600 -3.161 -115 459.859
2026-02-26 2026-02-24 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D 36,1300 -61.547 -2.224 463.020
2026-02-26 2026-02-24 4 Davidson Michael H. NAMS Ordinary Shares M - Exercise D 64.708 524.567
2026-02-24 2026-02-20 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale D 35,4600 -30.789 -1.092 53.500
2026-02-24 2026-02-20 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale D 35,0000 -14.692 -514 84.289
2026-01-29 2026-01-28 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 31,8000 -32.612 -1.037 24.353
2026-01-29 2026-01-28 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,9000 32.612 355 56.965
2026-01-29 2026-01-27 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 32,6200 -39.816 -1.299 24.353
2026-01-29 2026-01-27 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,9000 39.816 434 64.169
2026-01-27 2026-01-26 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 33,4500 -309 -10 24.353
2026-01-27 2026-01-26 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 32,7700 -34.091 -1.117 24.662
2026-01-27 2026-01-26 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,9000 34.400 375 58.753
2026-01-27 2026-01-23 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 34,3700 -12.767 -439 24.353
2026-01-27 2026-01-23 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 33,4400 -25.405 -850 37.120
2026-01-27 2026-01-23 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,9000 38.172 416 62.525
2026-01-22 2026-01-21 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 33,8000 -24.362 -823 58.382
2026-01-22 2026-01-21 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 33,2500 -15.422 -513 82.744
2026-01-22 2026-01-21 4 Somaiya Mayur Ian NAMS Ordinary Shares M - Exercise D 9,2600 39.784 368 98.166
2026-01-22 2026-01-20 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 32,3800 -19.604 -635 58.382
2026-01-22 2026-01-20 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 31,7800 -39.712 -1.262 77.986
2026-01-22 2026-01-20 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 30,6400 -900 -28 117.698
2026-01-22 2026-01-20 4 Somaiya Mayur Ian NAMS Ordinary Shares M - Exercise D 9,2600 60.216 558 118.598
2026-01-09 2026-01-07 4 Lewis William NAMS Ordinary Shares A - Award D 3.400 10.360
2026-01-09 2026-01-07 4 Davidson Michael H. NAMS Ordinary Shares A - Award D 81.000 459.859
2026-01-09 2026-01-07 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D -11.582 378.859
2026-01-09 2026-01-07 4 Gulfo Adele M. NAMS Ordinary Shares A - Award D 3.400 14.260
2026-01-09 2026-01-07 4 van der Kamp Hilde Johanna NAMS Ordinary Shares A - Award D 3.400 10.360
2026-01-09 2026-01-07 4 LANGE LOUIS G NAMS Ordinary Shares A - Award D 3.400 10.360
2026-01-09 2026-01-07 4 McKenna Mark C. NAMS Ordinary Shares A - Award D 3.400 10.360
2026-01-09 2026-01-07 4 Smither John W NAMS Ordinary Shares A - Award D 3.400 10.360
2026-01-07 2026-01-07 4 Somaiya Mayur Ian NAMS Ordinary Shares A - Award D 25.500 58.382
2026-01-07 2026-01-05 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D 33,2500 -5.118 -170 32.882
2026-01-07 2026-01-07 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares A - Award D 25.500 98.981
2026-01-07 2026-01-05 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale D 33,2500 -6.000 -200 73.481
2026-01-07 2026-01-07 4 Kooij Louise Frederika NAMS Ordinary Shares A - Award D 12.000 24.353
2026-01-07 2026-01-05 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 33,2500 -2.647 -88 12.353
2025-12-29 2025-12-26 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 35,3000 -43.872 -1.549 15.000
2025-12-29 2025-12-26 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,9000 5.000 54 58.872
2025-12-29 2025-12-26 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,0000 38.872 389 53.872
2025-12-29 2025-12-24 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 35,6800 -26.011 -928 15.000
2025-12-29 2025-12-24 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,0000 26.011 260 41.011
2025-12-29 2025-12-23 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 36,2100 -75.117 -2.720 15.000
2025-12-29 2025-12-23 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,0000 75.117 751 90.117
2025-09-17 2025-09-15 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 23,6953 660 16 3.028.524
2025-09-10 2025-09-09 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 26,1100 -96.896 -2.530 15.000
2025-09-10 2025-09-09 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 25,3100 -53.104 -1.344 111.896
2025-09-10 2025-09-09 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 10,0000 150.000 1.500 165.000
2025-09-10 2025-09-08 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 24,9900 1.260 31 3.027.864
2025-09-05 2025-09-03 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 25,0900 -18.073 -453 15.000
2025-09-04 2025-09-02 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 18.073 33.073
2025-08-27 2025-08-25 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 24,8600 -8.269 -206 15.000
2025-08-25 2025-08-22 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 25,4900 -7.658 -195 69.302
2025-08-25 2025-08-22 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 25,0800 -42.342 -1.062 76.960
2025-08-25 2025-08-21 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 24,2900 -50.000 -1.214 119.302
2025-08-13 2025-08-11 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 23,9787 471 11 3.026.604
2025-07-17 2025-07-16 4 Kling Douglas F NAMS Ordinary Shares S - Sale D 21,1000 -51.043 -1.077 44.000
2025-07-17 2025-07-16 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,9000 51.043 556 95.043
2025-07-17 2025-07-15 4 Kling Douglas F NAMS Ordinary Shares S - Sale D 22,1200 -3.544 -78 44.000
2025-07-17 2025-07-15 4 Kling Douglas F NAMS Ordinary Shares S - Sale D 21,3800 -44.025 -941 47.544
2025-07-17 2025-07-15 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,9000 47.569 519 91.569
2025-06-26 2025-06-25 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 18,2632 1.260 23 3.026.133
2025-06-26 2025-06-24 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 18,4343 2.520 46 3.024.873
2025-06-18 2025-06-16 4 Kling Douglas F NAMS Ordinary Shares S - Sale D 19,7500 -18.109 -358 44.000
2025-06-18 2025-06-16 4 Kling Douglas F NAMS Ordinary Shares S - Sale D 19,1900 -81.891 -1.571 62.109
2025-06-18 2025-06-16 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,9000 21.899 239 144.000
2025-06-18 2025-06-16 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,0000 78.101 781 122.101
2025-06-18 2025-06-16 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 19,4992 8.584 167 3.022.153
2025-06-03 2025-06-01 4 Marino Michael F III NAMS Ordinary Shares A - Award D 55.000 55.000
2025-06-03 2025-06-01 4 LANGE LOUIS G NAMS Ordinary Shares M - Exercise I 68 28.186
2025-05-19 2025-05-15 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -100.000 44.000
2025-05-19 2025-05-15 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,0000 100.000 1.000 144.000
2025-05-02 2025-05-01 4 LANGE LOUIS G NAMS Ordinary Shares M - Exercise I 69 28.118
2025-04-21 2025-04-14 4 LANGE LOUIS G NAMS Ordinary Shares M - Exercise I 69 28.049
2025-04-17 2025-04-15 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -910 44.000
2025-04-17 2025-04-15 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -99.090 44.910
2025-04-17 2025-04-15 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,0000 100.000 1.000 144.000
2025-04-17 2025-04-15 4 Gulfo Adele M. NAMS Ordinary Shares A - Award D 10.860 10.860
2025-03-28 2025-03-26 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 22,4851 1.135 26 3.013.569
2025-03-28 2025-03-26 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 8.269 23.269
2025-03-28 2025-03-26 4 LANGE LOUIS G NAMS Ordinary Shares M - Exercise D 3.102 10.062
2025-03-28 2025-03-26 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise D 45.481 79.481
2025-03-28 2025-03-26 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares A - Award I 19.302 169.302
2025-03-28 2025-03-26 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -16.539 44.000
2025-03-28 2025-03-26 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 16.539 60.539
2025-03-28 2025-03-26 4 Davidson Michael H. NAMS Ordinary Shares S - Sale D -12.258 390.441
2025-03-28 2025-03-26 4 Davidson Michael H. NAMS Ordinary Shares M - Exercise D 38.394 402.699
2025-03-28 2025-03-26 4 Davidson Michael H. NAMS Ordinary Shares A - Award D 30.992 364.305
2025-03-26 2025-03-24 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise I 150.000 150.000
2025-03-19 2025-03-17 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -100.000 44.000
2025-03-19 2025-03-17 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 10,0000 11.888 119 144.000
2025-03-19 2025-03-17 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 88.112 132.112
2025-03-06 2025-03-04 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 21,0245 4.005 84 3.012.434
2025-03-05 2025-03-04 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 20,3700 -150.000 -3.056 15.000
2025-03-05 2025-03-04 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 150.000 165.000
2025-02-20 2025-02-19 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -9.218 44.000
2025-02-20 2025-02-19 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 9.218 53.218
2025-02-20 2025-02-18 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -90.782 44.000
2025-02-20 2025-02-18 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 90.782 134.782
2025-01-31 2025-01-30 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -8.914 44.000
2025-01-31 2025-01-30 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -4.664 52.914
2025-01-31 2025-01-30 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 13.578 57.578
2025-01-31 2025-01-29 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -56.863 44.000
2025-01-31 2025-01-29 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 56.863 100.863
2025-01-29 2025-01-28 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D -3.405 38.000
2025-01-29 2025-01-28 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D -11.495 41.405
2025-01-29 2025-01-28 4 Somaiya Mayur Ian NAMS Ordinary Shares M - Exercise D 9,2600 14.900 138 52.900
2025-01-29 2025-01-27 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D -13.304 38.000
2025-01-29 2025-01-27 4 Somaiya Mayur Ian NAMS Ordinary Shares S - Sale D -33.679 51.304
2025-01-29 2025-01-27 4 Somaiya Mayur Ian NAMS Ordinary Shares M - Exercise D 9,2600 46.983 435 84.983
2025-01-29 2025-01-28 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -5.148 44.000
2025-01-29 2025-01-28 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -20.237 49.148
2025-01-29 2025-01-28 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 25.385 69.385
2025-01-29 2025-01-27 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -23.815 44.000
2025-01-29 2025-01-27 4 Kling Douglas F NAMS Ordinary Shares S - Sale D -80.359 67.815
2025-01-29 2025-01-27 4 Kling Douglas F NAMS Ordinary Shares M - Exercise D 104.174 148.174
2025-01-08 2025-01-07 4 Smither John W NAMS Ordinary Shares A - Award D 6.960 6.960
2025-01-08 2025-01-07 4 McKenna Mark C. NAMS Ordinary Shares A - Award D 6.960 6.960
2025-01-08 2025-01-07 4 Lewis William NAMS Ordinary Shares A - Award D 6.960 6.960
2025-01-08 2025-01-07 4 van der Kamp Hilde Johanna NAMS Ordinary Shares A - Award D 6.960 6.960
2025-01-08 2025-01-07 4 LANGE LOUIS G NAMS Ordinary Shares A - Award D 6.960 6.960
2025-01-07 2025-01-07 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares A - Award D 34.000 34.000
2025-01-07 2025-01-07 4 Davidson Michael H. NAMS Ordinary Shares A - Award D 123.529 123.529
2025-01-07 2025-01-07 4 Kooij Louise Frederika NAMS Ordinary Shares A - Award D 15.000 15.000
2025-01-07 2025-01-07 4 Audet Juliette Berangere NAMS Ordinary Shares A - Award D 14.000 15.104
2025-01-07 2025-01-07 4 JONES WILLIAM A JR NAMS Ordinary Shares A - Award D 43.000 43.000
2025-01-07 2025-01-07 4 Kling Douglas F NAMS Ordinary Shares A - Award D 44.000 44.000
2025-01-07 2025-01-07 4 Somaiya Mayur Ian NAMS Ordinary Shares A - Award D 38.000 38.000
2025-01-02 2024-12-30 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,5369 -29.846 -762 10.656.172
2024-12-30 2024-12-27 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,9522 -41.472 -1.076 10.686.018
2024-12-30 2024-12-26 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,0072 -33.438 -870 10.727.490
2024-12-26 2024-12-24 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,6639 -16.164 -415 10.760.928
2024-12-26 2024-12-23 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,4904 -25.132 -641 10.777.092
2024-12-26 2024-12-20 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,1274 -5.629 -147 10.802.224
2024-12-26 2024-12-20 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,5305 -44.143 -1.127 10.807.853
2024-12-20 2024-12-19 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,4452 -56.506 -1.438 10.851.996
2024-12-20 2024-12-18 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,5496 -46.210 -1.227 10.908.502
2024-12-20 2024-12-18 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,7172 -54.518 -1.402 10.954.712
2024-12-18 2024-12-17 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,4463 -47.736 -1.262 11.009.230
2024-12-18 2024-12-17 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,6019 -66.648 -1.706 11.056.966
2024-12-18 2024-12-16 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0000 -1.096 -27 11.123.614
2024-12-16 2024-12-13 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0106 -25.751 -644 11.124.710
2024-12-16 2024-12-12 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,1763 -25.963 -680 11.150.461
2024-12-16 2024-12-12 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,2500 -140.048 -3.536 11.176.424
2024-12-12 2024-12-11 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 27,1090 -4.894 -133 11.316.472
2024-12-12 2024-12-11 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,4050 -18.583 -491 11.321.366
2024-12-12 2024-12-11 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,2637 -130.561 -3.298 11.339.949
2024-12-12 2024-12-10 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 26,1509 -48.511 -1.269 11.470.510
2024-12-12 2024-12-10 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,2184 -259.739 -6.550 11.519.021
2024-11-19 2024-11-18 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0786 -33.273 -834 11.778.760
2024-11-19 2024-11-15 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0218 -8.530 -213 11.812.033
2024-11-15 2024-11-14 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0057 -9.832 -246 11.820.563
2024-11-15 2024-11-13 4 ForGrowth NAP B.V. NAMS Ordinary Shares S - Sale I 25,0043 -1.066 -27 11.830.395
2024-10-01 2024-10-01 4 Kooij Louise Frederika NAMS Ordinary Shares S - Sale D 15,7200 -45.000 -707 0
2024-10-01 2024-09-27 4 Kooij Louise Frederika NAMS Ordinary Shares M - Exercise D 45.000 45.000
2024-09-30 2024-09-26 4 Audet Juliette Berangere NAMS Ordinary Shares P - Purchase D 15,7000 1.104 17 1.104
2024-08-22 2024-08-20 4 Davidson Michael H. NAMS Ordinary Shares P - Purchase D 16,2700 5.000 81 209.784
2024-06-24 2024-06-20 4 Davidson Michael H. NAMS Ordinary Shares P - Purchase D 17,2617 5.000 86 204.784
2024-03-28 2024-03-26 4 Topper James N By Frazier Life Sciences X, L.P. NAMS Ordinary Shares P - Purchase I 21,5000 8.429 181 3.008.429
2024-03-27 2024-03-26 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares S - Sale I 21,5000 -190.476 -4.095 0
2024-03-27 2024-03-26 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares F - Taxes I 22,7200 -11.197 -254 190.476
2024-03-27 2024-03-26 4 Kastelein Johannes Jacob Pieter NAMS Ordinary Shares M - Exercise I 201.673 201.673
2024-02-21 2024-02-13 4 LANGE LOUIS G NAMS Ordinary Shares P - Purchase I 19,0000 5.000 95 24.878
2024-01-25 3/A LANGE LOUIS G NAMS Ordinary Shares D 19.878
2024-01-02 3 ForGrowth NAP B.V. NAMS Ordinary Shares I 11.831.461
2023-12-29 3 Bain Capital Life Sciences Investors, LLC See footnotes NAMS Ordinary Shares I 10.473.913
2023-12-29 3 Topper James N Frazier Life Sciences X, L.P. NAMS Ordinary Shares I 3.000.000
2023-12-29 3 Topper James N Frazier Lifesciences Sponsor LLC NAMS Ordinary Shares I 3.801.000
2023-12-29 3 LANGE LOUIS G NAMS Ordinary Shares D 9.878
2023-12-29 3 Davidson Michael H. NAMS Ordinary Shares D 199.784
2023-12-29 3 Davidson Michael H. NAMS Ordinary Shares I 608.779
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista